Table 5.
Estimated DGIs and Potential for Therapeutic Adjustment (n = 193)a
| Drug | % Patients Expected to Experience a DGI |
|---|---|
| Ondansetron | 1.6 |
| Capecitabine | 0.5 |
| Simvastatin | 2.1 |
| Escitalopram | 0.3 |
| Allopurinol | 0 |
| Citalopram | 0.3 |
| Tacrolimus | 0.8 |
| Codeine | 0.2 |
| Paroxetine | 0.1 |
| Clopidogrel | 0.6 |
| Phenytoin | 0.7 |
| Total | 7.1 |
| Recommendation | % Patients Expected to be Eligible for Therapeutic Adjustment |
| Strong CPIC recommendation | 3.8 |
| Moderate CPIC recommendation | 3.3 |
| Total | 7.1 |
aDGI = drug-gene interaction, CPIC = Clinical Pharmacogenetics Implementation Consortium.